Skip to main content

Advertisement

SpringerLink
Log in

Attitudes and practices regarding the use of methadone in US State and federal prisons

  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

In the United States, vigorous enforcement of drug laws and stricter sentencing guidelines over the past 20 years have contributed to an expanded incarcerted population with a high rate of drug use. One in five state prisoners reports a history of injection drug use, and many are opiate dependent. For over 35 years, methadone maintenance therapy has been an effective treatment for opiate dependence; however, its use among opiate-dependent inmates in the United States is limited. In June 2003, we conducted a survey of the medical directors of all 50 US states and the federal prison system to describe their attitudes and practices regarding methadone. Of the 40 respondents, having jurisdiction over 88% (n=1,266,759) of US prisoners, 48% use methadone, predominately for pregnant inmates or for short-term detoxification. Only 8% of respondents refer opiate-dependent inmates to methadone programs upon release. The results highlight the need to destigmatize the use of methadone in the incarcerated setting, expand access to methadone during incarceration, and to improve linkage to methadone treatment for opiate-dependent offenders who return to the community.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bureau of Justice Statistics. Corrections statistics: summary findings. Available at: http:// www.ojp.usdoj.gov/bjs/correct.htm. Accessed May 4, 2005.

  2. Federal Bureau of Investigation. Uniform crime reports: crime in the United States. Available at: http://www.fbi.gov/ucr/ucr.htm. Accessed May 4, 2005.

  3. Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep. 1999;114:14–29.

    Article  CAS  PubMed  Google Scholar 

  4. Center for Disease Control and Prevention. Drug use, HIV, and the criminal justice system. IDU HIV Prevention, 2001. Available at: http://www.cdc.gov/idu/facts/criminaljusticefactsheet. pdf. Accessed May 4, 2005.

  5. Califano JA. Behind Bars: Substance Abuse and America’s Prison Population. Population, CASA Report. New York, New York. National Center on Addiction and Substance Abuse at Columbia University; 1998.

    Google Scholar 

  6. Bureau of Justice Statistics. Substance abuse and treatment of state and federal prisoners, 1999. Available at: http://www.ojp.usdoj.gov/bjs/abstract/satsfp97.htm. Accessed May 4, 2005.

  7. Hammett TD, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities. Am J Public Health. 2002;92:1789–1794.

    PubMed  Google Scholar 

  8. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich JD. Hepatitis C in state correctional facilities. Prev Med. 1999;28:92–100.

    Article  CAS  PubMed  Google Scholar 

  9. Reindollar RW. Hepatitis C and the correctional population. Am J Med. 1999;107:100S-103S.

    Article  CAS  PubMed  Google Scholar 

  10. Centers for Disease Control and Prevention (CDC). Prevention and control of infections with hepatitis viruses in correctional settings. MM WR Morb Mortal Wkly Rep. 2003; 52:1–36.

    Google Scholar 

  11. Rapposelli KK, Kennedy MG, Miles JR, et al. HIV/AIDS in correctional settings: a salient priority for the CDC and HRSA. AIDS Educ Prev. 2002;14:103–113.

    Article  PubMed  Google Scholar 

  12. Nurco DN, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behav Sci Law. 1991;9:221–242.

    Google Scholar 

  13. Nurco DN, Stephenson PE, Hanlon TE. Affercare/relapse prevention and the self-help movement. Addiction. 1991;25:1179–1200.

    CAS  Google Scholar 

  14. Hanlon TE, Nurco DN, Kinlock TW, Duszynski KR. Trends in criminal activity and drug use over an addiction career. Am J Drug Alcohol Abuse. 1990;16:223–238.

    CAS  PubMed  Google Scholar 

  15. Inciardi JA, McBride D, Suratt H. The heroin street addict: profiling a national population. In: Inciardi JA, Harrison LD, eds. Heroin in the Age of Crack-Cocaine. Thousand Oaks, CA: Sage; 1998:31–50.

    Google Scholar 

  16. Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316:426–428.

    CAS  PubMed  Google Scholar 

  17. Bird SM, Hutchinson SJ. Male drug-related deaths in the fortnight after release from prison: Scotland. Addiction. 2003;98:185–190.

    Article  PubMed  Google Scholar 

  18. Singleton N, Taylor C, Farrell M, Marsden J. Drug-Related Mortality Among Newly Released Offenders. London: Communications Development Unit, Home Office; 2003.

    Google Scholar 

  19. Weatherburn D, Lind B. Heroin harm minimisation: do we really have to choose between law enforcement and treatment? Crime Justice Bull. 1999;46:1–11.

    Google Scholar 

  20. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area. Am J Public Health. 2001;91:1842–1846.

    CAS  PubMed  Google Scholar 

  21. Merrill J, Alterman A, Cacciola J, Rutherford M. Prior treatment history and its impact on criminal recidivism. J Subst Abuse Treat. 1999;17:313–319.

    Article  CAS  PubMed  Google Scholar 

  22. Dole V, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969;280:1372–1375.

    Article  CAS  PubMed  Google Scholar 

  23. McGlothlin WH, Anglin MD, Wilson BD. Outcome of the California civil addict commitments. Drug Alcohol Depend. 1976;1:165–181.

    Article  CAS  PubMed  Google Scholar 

  24. McLellan AT, Arndt IO, Metzger DS, et al. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959.

    Article  CAS  PubMed  Google Scholar 

  25. Magura S, Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001;68:62–74.

    CAS  PubMed  Google Scholar 

  26. Sees K, Delucci K, Masson C, et al. Methadone maintenance vs. 180-day psychologically enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000;283:1303–1310.

    Article  CAS  PubMed  Google Scholar 

  27. Nestler EJ, Aghanajanian GK. Molecular and cellular basis of addiction. Science. 1997;278:58–63.

    Article  CAS  PubMed  Google Scholar 

  28. Ward J, Mattick RP, Hall W, eds. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Australia: Harwood Academic Publishers; 1998.

    Google Scholar 

  29. Metzger D, Navaline H, Woody G. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;133:97–106.

    Google Scholar 

  30. Capelhom JRM, Ross MW. Methadone maintenance and the likelihood of risky needlesharing. Addiction. 1995;30:685–698.

    Google Scholar 

  31. Newman RG, Bashkow S, Cates M. Arrest histories before and after admission to methadone. Contemp Drug Probl. 1973:417–430.

  32. Center for Disease Control and Prevention. Substance abuse treatment for drug users in the cirminal justice system. IDU HIV Prevention, 2002. Available at: http:// www.cdc.gov/idu/facts/TreatmentFin.pdf. Accessed May 4, 2005.

  33. Martin SS, Butzin CA, Saum CA, Inciardi JA. Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: from prison to work release to aftercare. Prison J. 1999;79:294–320.

    Article  Google Scholar 

  34. Center for Disease Control and Prevention. Helping inmates return to the community. IDU HIV prevention, 2001. Available at: http://www.cdc.gov/idu/facts/cj-transition.pdf. Accessed May 4, 2005.

  35. Grinstead O, Zack B, Faigeles B. Reducing post release risk behavior among HIV seropositive inmates: the health promotion program. AIDS Educ Prev. 2001;13:109–119.

    Article  CAS  PubMed  Google Scholar 

  36. Travis J, Solomon AL, Waul M. From prison to home: the dimensions and consequences of prison reentry. Urban Health Institute, 2001. Available at: http://www.urban.org/ pdfs/from_prison_to_home.pdf. Accessed May 4, 2005.

  37. Dolan K, Wodak A. An international review of methadone provision in prisons. Addict Res. 1996;4:85–97.

    Google Scholar 

  38. Sibbald B. Methadone maintenance expands inside federal prisons. CMAJ. 2002; 167:1154.

    PubMed  Google Scholar 

  39. Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend. 2003;72:59–65.

    Article  PubMed  Google Scholar 

  40. Fallon BM. The Key Extended Entry Program (KEEP): from the community side of the bridge. Mt Sinai J Med. 2001;68:21–27.

    CAS  PubMed  Google Scholar 

  41. Tomasino V, Swanson AJ, Nolan J, Shuman HI. The Key Extended Entry Program (KEEP): a metha done treatment program for opiate-dependent inmates. Mt Sinai J Med. 2001;68:14–20.

    CAS  PubMed  Google Scholar 

  42. Gerra G, Ferri M, Polidori E, Santoro G, Zaimovic A, Sternieri E. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables. J Subst Abuse Treat. 2003;25:1–8.

    Article  PubMed  Google Scholar 

  43. Office of National Drug Control Policy. Consultation Document on Methadone/LAAM. Washington, DC: ONDCP; 1998.

    Google Scholar 

  44. Warren E, Viney R. CHERE: an economic evaluation of the prison methadone program in New South Wales, 2004: Available at: http://www.chere.uts.edu.au/pdf/rep22.pdf. Accessed May 4, 2005.

  45. Clarke JG, Stein MD, Hanna L, Sobota M, Rich JD. Active and former IDU report of HIV risk behaviors during periods of incarceration. Subst Abuse. 2001;22:209–216.

    Article  Google Scholar 

  46. Calzavara LM, Burchell AN, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction. 2003;98:1257–1265.

    Article  PubMed  Google Scholar 

  47. Koulierakis G, Gnardellis C, Agrafiotis D, Power KG. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction. 2000;95:1207–1216.

    Article  CAS  PubMed  Google Scholar 

  48. Champion JK, Taylor A, Hutchinson S, et al. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol. 2004;159:514–519.

    Article  CAS  PubMed  Google Scholar 

  49. Macalino GE, Vlahov D, Sandford S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;4:1218–1223.

    Article  Google Scholar 

  50. Magura S, Rosenblum A, Joseph H. Evaluation of in-jail methadone maintenance: preliminary results. NIDA Research Monograph. 1992;118:192–210.

    CAS  PubMed  Google Scholar 

  51. Rich JD, McKenzie M, Carleton JC, Rizzi MA, Wolf FA, Crosland C. Linkage to methadone upon release from incarceration: a model. Paper presented at: APHA 131 st Annual Meeting; November 19, 2003; San Francisco.

  52. United States Code of Federal Regulations Certification of Opioid Treatment Programs, 42 CFR §8, 2005. Available at: http://dpt.samhsa.gov/otp.htm. Accessed May 4, 2005.

Download references

Author information

Authors and Affiliations

  1. The Miriam Hospital/Brown Medical School, 164 Summit Avenue, 02906, Providence, Rhode Island

    Josiah D. Rich MD, MPH,  Amy E. Boutwell,  David C. Shield &  Michelle McKenzie

  2. Texas Tech University, Lubbock, Texas

    R. Garrett Key

  3. Rhode Island Hospital, Providence, Rhode Island

    Jennifer G. Clarke &  Peter D. Friedmann

Authors
  1. Josiah D. Rich MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy E. Boutwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David C. Shield
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Garrett Key
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michelle McKenzie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jennifer G. Clarke
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peter D. Friedmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josiah D. Rich MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rich, J.D., Boutwell, A.E., Shield, D.C. et al. Attitudes and practices regarding the use of methadone in US State and federal prisons. J Urban Health 82, 411–419 (2005). https://doi.org/10.1093/jurban/jti072

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1093/jurban/jti072

Keywords

Search

Navigation